The Nasdaq 100 dropped for the first time in three sessions, weighed down by declines in tech heavyweights including Tesla Inc.
was the biggest drag on the Dow Jones Industrial Average after it warned that higher costs for raw materials and transportation is a worsening threat.
While the earnings season has been generally strong so far, investors may be waiting for more robust beats to fan the next move higher.
What will TXN and AMD be thinking in the wake of this news? Is vertical integration now the state of the industry? Does INTC’s move in this direction pose a possible competitive challenge? We may have a chance to find out after the close.
Ho also expects continued high demand for the iPhone as a result of a delay in the launch last year and believes AAPL will continue to benefit as it controls a larger share of the market.
It has gained 19% this year.Tate & Lyle May Fade If Right Financial Partner Not Found: ReactThe company “continues to successfully execute its strategy and remains confident in the future growth prospects of the company,” it said in a statement, adding that the transaction envisaged “would enable Tate & Lyle and the new business to focus their respective strategies and capital allocation priorities.” For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Wall Street’s main indexes rose on Monday as Tesla shares gained ahead of the electric-car maker’s earnings report, which would kick off this week’s results from heavyweight technology companies.
HSBC Holdings PLC beat quarterly profit forecasts and released $400 million it had set aside to cover bad loans caused by the pandemic, as rapid vaccine rollouts in the United States and Britain raise hopes for an economic recovery.
General Electric Co’s turnaround plans looked dead in the water to many last spring when its lucrative jet engine business became another victim of the coronavirus pandemic as global air travel dried up.
The low support, not including abstentions, for the non-binding proposal comes after the Office of the Illinois State Treasurer urged other shareholders to vote “No” on the company’s pay practices, namely because J&J sets aside certain litigation costs when calculating executive compensation, including from the U.S.
A Milan judge on Tuesday indicted the Italian units of Novartis and Bayer on charges of operating a scheme to cheat the regional public health service in Lombardy, legal and judicial sources said.
The Series D funding round is structured as a $225 million investment, with another $300 million equity commitment from SoftBank available at Exscientia’s discretion.“Exscientia’s innovative use of AI to discover and design better quality drugs with greater efficiency has the potential to create important medicines faster than ever before,” SoftBank Investment Advisers’ Managing Partner Eric Chen said in the statement.The company says it has more than 20 projects in development, including two currently in clinical trials, and has partnered with firms including Bristol-Myers Squibb, Bayer AG, and Sanofi, as well as several biotech firms, Chief Financial Officer Ben Taylor said in an email.The investment is SoftBank’s latest in the U.K.